Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Ekso Bionics Holdings Inc

EKSO
Current price
0.69 USD -0.042 USD (-5.68%)
Last closed 0.71 USD
ISIN US2826443010
Sector Healthcare
Industry Medical Instruments & Supplies
Exchange NASDAQ
Capitalization 14 076 777 USD
Yield for 12 month -65.80 %
1Y
3Y
5Y
10Y
15Y
EKSO
21.11.2021 - 28.11.2021

Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. The company provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; Ekso Indego Therapy, an adjustable and lower-limb powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; Ekso Nomad, a power knee ankle foot orthosis; and Ekso EV, a wearable upper body exoskeleton that elevates and supports a worker's arms to assist with tasks from chest height to overhead. Ekso Bionics Holdings, Inc. was founded in 2005 and is headquartered in San Rafael, California. Address: 101 Glacier Point, San Rafael, CA, United States, 94901

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

5.50 USD

P/E ratio

Dividend Yield

Current Year

+18 279 000 USD

Last Year

+12 912 000 USD

Current Quarter

+4 129 000 USD

Last Quarter

+4 950 000 USD

Current Year

+9 079 000 USD

Last Year

+6 214 000 USD

Current Quarter

+2 209 000 USD

Last Quarter

+2 637 000 USD

Key Figures EKSO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -10 037 000 USD
Operating Margin TTM -63.91 %
PE Ratio
Return On Assets TTM -24.17 %
PEG Ratio
Return On Equity TTM -73.89 %
Wall Street Target Price 5.50 USD
Revenue TTM 17 682 000 USD
Book Value 0.68 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -10.40 %
Dividend Yield
Gross Profit TTM 6 749 000 USD
Earnings per share -0.64 USD
Diluted Eps TTM -0.64 USD
Most Recent Quarter III 2024
Quarterly Earnings Growth YOY
Profit Margin -62.95 %

Dividend Analytics EKSO

Max Ratio

>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Dividend History EKSO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:15
Payout Ratio
Last Split Date 25.03.2020
Dividend Date 25.03.2020

Stock Valuation EKSO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 0.60
Price Sales TTM 0.80
Enterprise Value EBITDA 0.46
Price Book MRQ 0.84

Financials EKSO

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators EKSO

For 52 weeks

0.50 USD 3.13 USD
50 Day MA 0.85 USD
Shares Short Prior Month 86 763
200 Day MA 1.13 USD
Short Ratio 1.03
Shares Short 121 484
Short Percent 0.57 %